NeuroSense regains $1 bid compliance, seeks Nasdaq hearing over $35 million MVLS

Oct 2, 2026 20:15 (21d ago)

Verifying

NeuroSense plans to appeal Nasdaq’s determination concerning its minimum market value requirement.
$35 million MVLS compliance was not restored by the September 29, 2026 deadline.
Nasdaq confirmed NeuroSense regained minimum bid-price compliance after its 1-for-20 reverse split.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.